Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)
- First Posted Date
- 2016-07-14
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Autifony Therapeutics Limited
- Target Recruit Count
- 15
- Registration Number
- NCT02832128
- Locations
- π¬π§
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
π¬π§Royal National Throat, Nose and Ear Hospital, London, United Kingdom
π¬π§Manchester Royal Infirmary, Manchester, United Kingdom
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
- First Posted Date
- 2015-01-26
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- Autifony Therapeutics Limited
- Target Recruit Count
- 78
- Registration Number
- NCT02345031
- Locations
- πΊπΈ
The University of Mississippi Medical Center, Jackson, Mississippi, United States
πΊπΈQPS MRA (Miami Research Associates), Miami, Florida, United States
πΊπΈSacramento ENT, Sacramento, California, United States
Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo
- First Posted Date
- 2014-12-12
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Autifony Therapeutics Limited
- Target Recruit Count
- 91
- Registration Number
- NCT02315508
- Locations
- π¬π§
Bristol Royal Infirmary, Bristol, United Kingdom
π¬π§Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom
π¬π§Freeman Hospital, Newcastle, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath